Scarica l'app Stockscreener
34.63
0.14%
0.048
Precedente Chiudi:
$34.59
Aprire:
$34.76
Volume 24 ore:
9,582
Relative Volume:
0.69
Capitalizzazione di mercato:
$N/A
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
-1.30%
1M Prestazione:
+4.42%
6M Prestazione:
+32.40%
1 anno Prestazione:
+35.56%
Intervallo 1D:
$34.50
$34.91
Intervallo di 1 settimana:
$34.10
$35.94
Portata 52W:
$20.10
$36.14
Tema Oncology Etf Stock (CANC) Company Profile
Nome
Tema Oncology Etf
Settore
Industria
Telefono
-
Indirizzo
-
Confronta CANC con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CANC
Tema Oncology Etf
|
34.63 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
335.99 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
681.76 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
685.17 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
262.61 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
613.62 | 124.43B | 0 | 0 | 0 | 0.00 |
Tema Oncology Etf Borsa (CANC) Ultime notizie
ETFs Investing in Ascentage Pharma Group International Unsponsored ADR Stocks - TradingView
Healthcare stocks are red-hot. Here are 3 picks from a fund manager up 41% this year. - Yahoo Finance
Discipline and Rules-Based Execution in CANC Response - news.stocktradersdaily.com
Tema’s Oncology ETF (CANC) Surpasses $100m in Assets Amidst Strong 2025 Performance - PharmiWeb.com
The AI Pharma Rally Is Real — And Cancer May Soon Be Chronic, Not Deadly - Sahm
Be Thankful to These ETFs This Year - sharewise.com
Behavioral Patterns of CANC and Institutional Flows - news.stocktradersdaily.com
Inside the Recent Strength in Biotech ETFs - TradingView
(CANC) Movement Within Algorithmic Entry Frameworks - news.stocktradersdaily.com
How (CANC) Movements Inform Risk Allocation Models - news.stocktradersdaily.com
Biotech ETFs Bounce Back in 2025: Here's Why - sharewise.com
Aug PostEarnings: Is Tema ETF Trust Tema International stock among top earnings playsInsider Selling & Reliable Volume Spike Trade Alerts - nchmf.gov.vn
5 Small-cap Biotech ETFs to Watch in 2025 - Investing News Network
ETFs with Bristol-Myers Squibb Company ( BMY ) Exposure - ETF Database
Tema Launches Alternative Asset Managers ETF (AAUM) - Business Wire
What hedge fund moves indicate for Tema ETF Trust Tema Monopolies stockLayoff News & Growth Focused Stock Reports - newser.com
Short Interest in Tema Oncology ETF (NASDAQ:CANC) Increases By 264.8% - Defense World
Tema Etfs LLC Grows Stock Holdings in CG Oncology, Inc. $CGON - MarketBeat
Tema Surpasses $1bn AUM Two Years After Launch, Strengthens Team With Key Growth Hires - Business Wire
How to Take Advantage of moves in (CANC) - news.stocktradersdaily.com
Analysts Predict Tema Oncology ETF to Reach $40, with Stocks CELC, ACLX, and ZYME Showing Significant Upside Potential - AInvest
Summit Therapeutics Explodes 12%: Legal Probe Ignites Volatility Amid Regulatory Crosshairs - AInvest
Summit Therapeutics Soars 16.5% Amid Regulatory Crossroads and Whale Activity - AInvest
When (CANC) Moves Investors should Listen - news.stocktradersdaily.com
Tema Announces Liquidation of Two ETFs - Business Wire
5 Small-cap Biotech ETFs to Watch - Nasdaq
(CANC) Investment Report - news.stocktradersdaily.com
(CANC) Technical Data - news.stocktradersdaily.com
Bristol-Myers Squibb At ASCO 2025: A Resilient Play Amid Market Turbulence (NYSE:BMY) - Seeking Alpha
ITM and Radiopharm Sign Supply Agreement for n.c.a. Lutetium-177 - Investing News Network
Biotech Outperformance: Can’t Take What’s Already Earned - Seeking Alpha
AAPG Stock Price and Chart — NASDAQ:AAPG - TradingView
7 Best-Performing Biotech ETFs for March 2025 - NerdWallet
Tema Launches World’s First Electrification ETF ($VOLT) - Business Wire
Disruptive Theme of the Week: Breakthroughs in Medicine - ETF Trends
Tema ETF Trust Tema Oncology ETF (NASDAQ: CANC)Related Research - intelligentinvestor.com.au
5 Small-cap Biotech ETFs to Watch (Updated 2024) - Nasdaq
Tema American Reshoring ETF: Benefiting From The Return Of U.S. Manufacturing - Seeking Alpha
CANC Financial Statements & ChartsTema Etf TrustTema Oncology Etf MacroTrends - CMLviz
Tema Neuroscience And Mental Health ETF (MNTL) stock price, news, quote and history - Yahoo Finance UK
Tema Oncology ETF (CANC) Holdings - Yahoo! Finance Canada
Tema Oncology ETF (CANC) stock price, news, quote and history - Yahoo Finance UK
Tema Oncology ETF (CANC) Stock Trends and Sentiment 2025 - MarketBeat
Tema ETFs CIO on Investment Opportunities in Biotech - CMC Markets
Pursuing A Better Way To Invest In Life Sciences | Opto Partners - CMC Markets
How Big Pharma Is Taking A Page Out Of Novartis' Playbook - Investor's Business Daily
10 Best Performing Biotech ETFs in 2024 - Yahoo Finance
9 Best Biotech ETFs for 2024 - AOL.com
The 5 Best Biotech ETFs of 2024 - ETF.com
11 Best Biotech ETFs To Buy - Yahoo Finance
Tema Oncology ETF (CANC) Stock Price, News, Quote & History - Yahoo! Finance Canada
Tema Oncology Etf Azioni (CANC) Dati Finanziari
Non sono disponibili dati finanziari per Tema Oncology Etf (CANC). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
0.33%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):